Clearlake and Charlesbank to inject $175m into distressed Symplr
Private equity firms Clearlake Capital Group and Charlesbank Capital Partners have agreed to provide around $175m of preferred equity to healthcare software provider Symplr as part of a restructuring designed to shore up the company's finances and push out debt maturities, according to a report by Bloomberg.
We haven't written up this one. Private Equity Wire has the full story — the link below goes straight to it.
